104 results
Page 3 of 6
6-K
EX-99.1
c65njjdp269ca9az
27 Apr 23
Fourth quarter and full year 2022 financial results and business update
8:30am
6-K
EX-99.1
h3rqg
18 Apr 23
Current report (foreign)
9:19am
6-K
EX-99.1
fbiyxmm33t rli3tm
18 Apr 23
Current report (foreign)
8:00am
6-K
EX-99.1
n3mga6s
6 Dec 22
Current report (foreign)
6:00am
6-K
EX-99.1
oki9glou6lzm 0t
5 Dec 22
Evaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02
10:44am
6-K
EX-99.1
9jod2ud g2
14 Nov 22
Evaxion Announces Third Quarter 2022 Financial Results and Business Update
7:21am
6-K
EX-99.1
0p5l 4hnt
10 Nov 22
Evaxion CEO comments on strategic focus
6:00am
424B5
3don35k
4 Oct 22
Prospectus supplement for primary offering
8:52am
6-K
EX-99.1
k88vfu0
21 Sep 22
Important Milestone Reached for Evaxion Biotech’s EVX-01 Personalized Cancer Therapy
11:43am
424B4
7yfw9mn dw
30 Aug 22
Prospectus supplement with pricing info
4:52pm
F-1/A
goytm59
22 Aug 22
Registration statement (foreign) (amended)
4:40pm
6-K
EX-99.2
ive9rx3fdob31d 7s
11 Aug 22
Current report (foreign)
4:30pm
6-K
EX-99.1
pes4ibxkm92 sn
10 Aug 22
Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update
12:00am
6-K
EX-99.1
3vuh6dbz94w9f8sv
2 Aug 22
Evaxion Biotech A/S Announces Executive Management Changes
7:13am
F-1
s264qzhl3m4oc
7 Jul 22
Registration statement (foreign)
4:45pm
6-K
q4f 79j77lm79j
1 Jul 22
Current report (foreign)
5:09pm
6-K
EX-99.1
llxg8j ysp8l
30 Jun 22
Evaxion Biotech Announces Gonorrhea as Second Bacterial Product Target
7:00am
6-K
EX-99.1
3jyz 493vb6a
23 Jun 22
Current report (foreign)
7:38am
6-K
EX-99.1
kpmjw4f i4g
7 Jun 22
Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital
5:05pm